Penn Bioethics Seminar Series (PBS): Andrew Murray, PhD. "Our Dollars, Our Cells: University Biomedical Research as Public and Private Good"

12:00pm - 1:00pm • Hybrid 1402 Blockley Hall, 423 Guardian Drive

2023-10-31 12:00:00 2023-10-31 13:00:00 America/New_York Penn Bioethics Seminar Series (PBS): Andrew Murray, PhD. "Our Dollars, Our Cells: University Biomedical Research as Public and Private Good" Our Dollars, Our Cells: University Biomedical Research as Public and Private Good Andrew Murray, PhD Postdoctoral Fellow in Ethical, Legal, and Social Implications of Genetics and Genomics Department of Medical Ethics and Health Policy University of Pennsylvania | Perelman School of Medicine In the United States, the research university has long been ground zero for the basic research that leads to technological innovation. Universities have historically relied on public research dollars delivered with the promise that academic research will ultimately deliver public goods via the marketplace. In the postgenomic biosciences especially, this seemingly straightforward relationship between the public dollars that fund research into cutting-edge treatments and the private property that often results is in flux. Among other factors, controversies and crises have compelled universities to reconfigure their relationships to both the public and private domains. Analyzing these shifts is vital for understanding the future of biomedical research and how it contributes to health ethics, equity, and justice. Lunch provided for in-person participants. Streaming available via Zoom. Hybrid 1402 Blockley Hall, 423 Guardian Drive Penn Medical Ethics

In the United States, the research university has long been ground zero for the basic research that leads to technological innovation. Universities have historically relied on public research dollars delivered with the promise that academic research will ultimately deliver public goods via the marketplace. In the postgenomic biosciences especially, this seemingly straightforward relationship between the public dollars that fund research into cutting-edge treatments and the private property that often results is in flux. Among other factors, controversies and crises have compelled universities to reconfigure their relationships to both the public and private domains. Analyzing these shifts is vital for understanding the future of biomedical research and how it contributes to health ethics, equity, and justice.